Hi Everyone,

The third annual conference on Low Dose Naltrexone (LDN) is scheduled
for October 20th at Vanderbilt University, Nashville, Tennessee. A
number of healthcare professionals will be presenting their experiences
using LDN in a clinical setting to treat cancer, Crohn's disease,
multiple sclerosis, and other diseases. For more information, visit

http://www.ldninfo.org/events.htm

This is a recently updated report listing various conditions for which
LDN may be of benefit:

http://www.digitalnaturopath.com/treat/T74481.html

One check next to the condition means LDN "may do some good," two checks
mean LDN is "likely to help," and three checks means LDN is "highly
recommended."

With best wishes,

Dudley Delany


http://profiles.yahoo.com/dudley_delany